An AI model developed at Severance Hospital of the Yonsei University College of Medicine in South Korea is set to be translated into an online clinical tool to help doctors estimate the risk of early liver metastasis in pancreatic cancer patients using routine blood tests.
The model, called LiMPC, was trained on blood test data from approximately 2,657 patients with pancreatic cancer treated at Severance Hospital.
The research team at Severance Hospital externally validated the model on 272 patients across five other Korean hospitals, including Gangnam Severance Hospital and Yongin Severance Hospital.
The AI model developed to assess liver metastasis risk, according to the researchers, could serve as a complementary method to conventional imaging, particularly in early-stage assessments where metastases are difficult to detect.
【MORE】